Pixantrone is an aza-anthracenedione and DNA intercalator which inhibits topoisomerase II. It is similar in structure to anthracyclines such as mitoxantrone, but exerts fewer toxic effects on cardiac tissue. [2] The lower cardio-toxic effects of pixantrone may be explained, in part, by its redox inactivity [3]. Pixantrone does not bind iron and promotes the ...
Currently in Phase III investigation for treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma in patients who have failed two prior lines of therapy. Presently, no standard therapy exists for patients with relapsed or refractory NHL. [2] After first line therapy has been initiated, most patients have received their lifetime limit of doxorubi...
Centre Hospitalier de Jolimont, Haine-Saint-Paul, Belgium
Clinique Victor Hugo, Le Mans, France
AZ Sint Jan, Brugge, Belgium
Children's Hospital Los Angeles, Los Angeles, California, United States
UTHSCSA-Cancer Therapy-Research Center, San Antonio, Texas, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.